Cell Culture and Bioprocessing
Stem cells are the basic materials of body cells from that all different cells will be specialized and functions are generated. Below the proper condition with in the body or a laboratory, stem cells divide to create a lot of cells called daughter cells.
These daughter cells will either become new stem cells (self-renewal) or else become specialized cells with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No different cell with in the body has the natural ability to generate new type of cell.
- Increase understanding of how diseases occur
- Generate healthy cells to replace diseased cells (regenerative medicine)
- Test new drugs for safety and effectiveness
- Embryonic stem cells
- Adult stem cells
- Adult cells altered to have properties of embryonic stem cells
- Perinatal stem cells
Related Conference of Cell Culture and Bioprocessing
September 24-25, 2026
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
Paris, France
November 16-17, 2026
19th International Conference on Human Genomics and Genomic Medicine
Tokyo, Japan
Cell Culture and Bioprocessing Conference Speakers
Recommended Sessions
- Advanced Gene Therapeutics
- Cell Culture and Bioprocessing
- Bioengineering Therapeutics
- Cell Biology
- Cell Cycle/Proliferation
- Cell Death and Viability
- Cell Science and Stem Cell Research
- Cellular Signaling
- Cellular Therapies
- Clinical Trials and Research in Stem Cell in Cancer Therapy
- Epidermis Stem Cell & Cancer Epidemiology
- Human Gene Therapy
- Immunotherapy
- Molecular Epigenetics
- Nano-Therapy
- Nanotechnology in Stem Cell
- Regenerative Medicine
- Regulatory and Ethical Issues of Therapies.
- Stem Cell in Drug Development
- Stem Cell Therapies
Related Journals
Are you interested in
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)

